Table:
text: Trubion
Former product pipeline
Former product pipeline
Name_ Platform Indication Status_ Collaboration
TRU-015 SMIP Rheumatoid arthritis Phase 2b Wyeth
SBI-087 SMIP Rheumatoid arthritis Phase 1 Wyeth
SBI-087 SMIP Systemic lupus erythematosus Phase 1 Wyeth
TRU-016 SMIP Chronic lymphocytic leukemia Phase 1/2 Trubion Proprietary Technology
TRU-016 SMIP Non-Hodgkin lymphoma Pre-clinical Trubion Proprietary Technology
TRU-016 SMIP Autoimmune disease and inflammation Pre-clinical Trubion Proprietary Technology

Question: Which company collaborated on Trubion's SBI-087 for rheumatoid arthritis?

Question: What company partnered with Trubion for non-Hodgkin lymphoma?

Question: Which company has worked on preclinical autoimmune diseases and inflammation for Trubion?

Question: Which study included autoimmune diseases and inflammation from Trubion?

Question: What was the goal of phase 2b status for Trubion?

Question: Which company has worked with Trubion in Non-Hodgkin Lymphoma?